Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access?

Abstract

are accepted on a 12-month basis. Prices are subject to change without notice. Current prices are in effect for back volumes and back issues. Back issues sold in conjunction with a subscription rate are on a prorated basis. Single issues, both current and back, exist in limited quantities and are offered for sale subject to availability.